Pediatric battery-related emergency department visits in the United States, 1990-2009

Samantha J Sharpe1, Lynne M Rochette, Gary A Smith

  • 1Center for Injury Research and Policy, The Research Institute at Nationwide Children's Hospital, 700 Children's Dr, Columbus, OH 43205, USA.

Pediatrics
|May 16, 2012
PubMed

Insights

Battery-related emergency department (ED) visits among children increased significantly from 1990-2009. These findings highlight the urgent need for enhanced prevention strategies to protect children from battery hazards.

Area of Science:

  • Pediatric Emergency Medicine
  • Public Health Surveillance
  • Injury Prevention

Background:

  • Battery-related injuries represent a significant public health concern among children.
  • Previous research indicates a need for updated epidemiological data on these incidents.

Purpose of the Study:

  • To analyze the epidemiology of battery-related emergency department (ED) visits in children under 18 years in the United States.
  • To identify trends, common exposure routes, and battery types associated with pediatric ED visits.

Main Methods:

  • Utilized the National Electronic Injury Surveillance System (NEISS) for a nationally representative sample of US ED visits from 1990 to 2009.
  • Categorized battery exposures into ingestion, mouth, ear canal, and nasal cavity insertion based on diagnosis codes and case narratives.

Main Results:

  • An estimated 65,788 pediatric ED visits occurred due to battery exposure over 20 years, with an increasing trend.
  • Battery ingestion was the most common exposure route (76.6%), with button batteries implicated in most cases (83.8%).
  • The average annual visit rate was 4.6 per 100,000 children, with a mean age of 3.9 years; 60.2% of patients were male.

Conclusions:

  • Battery ingestions and insertions pose a substantial risk to children, particularly those aged 5 years and younger.
  • The rising incidence of battery-related ED visits necessitates intensified public health interventions and prevention efforts.
  • Most children were treated and released, but the overall trend underscores the severity of the hazard.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...